Publication | Closed Access

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Neurodegenerative DiseasesMedicinePsychotropic MedicationPsychopharmacologyPharmacotherapyNeurologyPhase 2Dose-ranging StudyPharmacology